MODERATE-TO-SEVERE PRURITUS

Clinical trials for MODERATE-TO-SEVERE PRURITUS explained in plain language.

Never miss a new study

Get alerted when new MODERATE-TO-SEVERE PRURITUS trials appear

Sign up with your email to follow new studies for MODERATE-TO-SEVERE PRURITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for dialysis patients suffering from debilitating itch

Symptom relief Recruiting now

This study is testing whether a dissolving tablet called nalfurafine hydrochloride can safely reduce moderate to severe itching in people receiving peritoneal dialysis for kidney failure. It will enroll 93 participants who will take the medication for 4 weeks. The main goal is to…

Matched conditions: MODERATE-TO-SEVERE PRURITUS

Phase: NA • Sponsor: Guangdong Provincial People's Hospital • Aim: Symptom relief

Last updated Mar 30, 2026 14:30 UTC

MODERATE-TO-SEVERE PRURITUS

Get alerted when new MODERATE-TO-SEVERE PRURITUS trials appear

New hope for dialysis patients suffering from debilitating itch